Stocks › RGC

Regencell Bioscience Holdings Ltd

RGC·Nasdaq·USD
$4.18
-0.18 (-4.13%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
RGC
Regencell Bioscience Holdings Ltd · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RGCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of RGC by members of U.S. Congress · 13 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Gary J. PalmerGary J. PalmerHouse · R · AL RGCRegencell Bioscience Holdings Ltd · Stock Purchase
$1,001 - $15,000
Sep 29, 2018 Apr 4, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH RGCRegencell Bioscience Holdings Ltd · Stock Sale
$100,001 - $250,000
Feb 21, 2018 Feb 14, 2018 Filing ↗
Lois FrankelLois FrankelHouse · D · FL RGCRegencell Bioscience Holdings Ltd · Stock Sale
$1,001 - $15,000
Jan 23, 2018 Jan 8, 2018 Filing ↗
Lois FrankelLois FrankelHouse · D · FL RGCRegencell Bioscience Holdings Ltd · Stock Sale
$1,001 - $15,000
Jan 23, 2018 Jan 9, 2018 Filing ↗
Michael F. BennetMichael F. BennetSenate · D · CO RGCRegencell Bioscience Holdings Ltd · Stock Sale
$500,001 - $1,000,000
Dec 21, 2017 Dec 8, 2017 Filing ↗
Lois FrankelLois FrankelHouse · D · FL RGCRegencell Bioscience Holdings Ltd · Stock Sale
$1,001 - $15,000
Dec 20, 2017 Dec 8, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH RGCRegencell Bioscience Holdings Ltd · Stock Purchase
$15,001 - $50,000
Jun 22, 2017 Jun 1, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH RGCRegencell Bioscience Holdings Ltd · Stock Purchase
$1,001 - $15,000
Jun 7, 2017 May 31, 2017 Filing ↗
Michael F. BennetMichael F. BennetSenate · D · CO RGCRegencell Bioscience Holdings Ltd · Stock Sale
$500,001 - $1,000,000
Apr 10, 2017 Mar 28, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH RGCRegencell Bioscience Holdings Ltd · Stock Sale
$15,001 - $50,000
Feb 7, 2017 Jan 30, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH RGCRegencell Bioscience Holdings Ltd · Stock Purchase
$1,001 - $15,000
Feb 7, 2017 Jan 26, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH RGCRegencell Bioscience Holdings Ltd · Stock Sale
$15,001 - $50,000
Feb 7, 2017 Jan 31, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH RGCRegencell Bioscience Holdings Ltd · Stock Purchase
$15,001 - $50,000
Oct 5, 2015 Sep 22, 2015 Filing ↗

Whale Activity

Position changes in RGC reported for 2026-09-30 by 45 institutional filers
Increased: 10New: 8Held: 4Decreased: 7Closed: 14No prior filing: 2
  • Increased10
  • New8
  • Held4
  • Decreased7
  • Closed14
  • No prior filing2
FilerSharesValueChange
GEODE CAPITAL MANAGEMENT, LLC423.4K$2.6Mincreased
Cerity Partners LLC128.7K$801Knew
Legal & General Group Plc108.8K$675Kdecreased
JANE STREET GROUP, LLC81.7K$508Kdecreased
XTX Topco Ltd49.1K$305Kdecreased
SUSQUEHANNA INTERNATIONAL GROUP, LLP43.1K$268Kincreased
MORGAN STANLEY40.6K$252Kincreased
GSA CAPITAL PARTNERS LLP38.9K$242Knew
Savant Capital, LLC18.3K$114Knew
Polar Asset Management Partners Inc.17.0K$106Knew
CIBC Asset Management Inc15.3K$95Kheld
BlackRock, Inc.4,886$30Kdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by RGC insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

1,106 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
CAMPBELL MICHAEL LDirector Disposition to issuer −703.7K $23.00 $16.2M Feb 28, 2018 Form 4 ↗
YEMENIDJIAN ALEXDirector Disposition to issuer −21.9K $23.00 $503K Feb 28, 2018 Form 4 ↗
TYRRELL JACKDirector Disposition to issuer −136.7K $23.00 $3.1M Feb 28, 2018 Form 4 ↗
TYRRELL JACKDirector Disposition to issuer −100.0K $23.00 $2.3M Feb 28, 2018 Form 4 ↗
TYRRELL JACKDirector Disposition to issuer −33.1K $23.00 $761K Feb 28, 2018 Form 4 ↗
TYRRELL JACKDirector Disposition to issuer −10.4K $23.00 $240K Feb 28, 2018 Form 4 ↗
THOMAS LEE MDirector Disposition to issuer −46.6K $23.00 $1.1M Feb 28, 2018 Form 4 ↗
THOMAS LEE MDirector Disposition to issuer −33.2K $23.00 $763K Feb 28, 2018 Form 4 ↗
THOMAS LEE MDirector Disposition to issuer −10.4K $23.00 $240K Feb 28, 2018 Form 4 ↗
KEYTE DAVID HDirector Disposition to issuer −5,767 $23.00 $133K Feb 28, 2018 Form 4 ↗
KEYTE DAVID HDirector Disposition to issuer −5,767 $23.00 $133K Feb 28, 2018 Form 4 ↗
KEYTE DAVID HDirector Disposition to issuer −73.6K $23.00 $1.7M Feb 28, 2018 Form 4 ↗
KAPLAN STEPHEN ADirector Disposition to issuer −161.0K $23.00 $3.7M Feb 28, 2018 Form 4 ↗
Brymer Charles EDirector Disposition to issuer −75.8K $23.00 $1.7M Feb 28, 2018 Form 4 ↗
BELL THOMAS D JRDirector Disposition to issuer −132.4K $23.00 $3.0M Feb 28, 2018 Form 4 ↗
BRANDOW PETER BEVP, General Counsel, Sec. Disposition to issuer −236.5K $23.00 $5.4M Feb 28, 2018 Form 4 ↗
Ownby DavidEVP, CFO and Treasurer Disposition to issuer −256.8K $23.00 $5.9M Feb 28, 2018 Form 4 ↗
DUNN GREGORY WPresident and COO Disposition to issuer −98.4K $23.00 $2.3M Feb 28, 2018 Form 4 ↗
MILES AMY EChief Executive Officer · Director Disposition to issuer −740.8K $23.00 $17.0M Feb 28, 2018 Form 4 ↗
ANSCHUTZ PHILIP F10% owner Disposition to issuer −23.7M — — Feb 28, 2018 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding RGC · SEC Form N-PORT
FundSharesValue% of fundAs of
Invesco S&P Emerging Markets Momentum ETF
Invesco Exchange-Traded Fund Trust II
478$3K0.01%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list RGC's shares (CUSIP G7487R100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming Regencell Bioscience Holdings Ltd as client

No lobbying filings found naming Regencell Bioscience Holdings Ltd as the client.

Government Contracts

Federal awards to Regencell Bioscience Holdings Ltd · USAspending

No federal contract awards found for Regencell Bioscience Holdings Ltd.

U.S. Patents

Recent USPTO applications naming Regencell Bioscience Holdings Ltd

No USPTO patent applications found for Regencell Bioscience Holdings Ltd.

Annual Financials

From RGC's 10-K filings · XBRL

SEC's XBRL figures for Regencell Bioscience Holdings Ltd include no full-year results from a 10-K in US dollars, so there is no table to show. Companies based abroad usually report annually on Form 20-F instead.

Stock Splits

Every split and reverse split in the price history
  • 38-for-1Stock splitJun 16, 2025

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About Regencell Bioscience Holdings Ltd

From SEC EDGAR company records
Industry (SIC 2833)Medicinal Chemicals & Botanical Products
SectorHealthcare
HeadquartersHONG KONG
IncorporatedE9